PU.1 controls fibroblast polarization and tissue fibrosisThomas Wohlfahrt, Andreas Ramming|Nature|2019Cited by 187
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Maria Gabriella Raimondo, Ricardo Grieshaber‐Bouyer et al.|Annals of the Rheumatic Diseases|2024Cited by 150
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune DiseaseMelanie Hagen, Ricardo Grieshaber‐Bouyer, Laura Bucci et al.|New England Journal of Medicine|2024Cited by 111
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trialJohannes Knitza, Martin Welcker, Jacob Mohn et al.|Arthritis Research & Therapy|2021Cited by 73
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Maria Gabriella Raimondo, Markus Eckstein et al.|Annals of the Rheumatic Diseases|2025Cited by 35